홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

필로카르핀

Pilocarpine

HCID 5910
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
54-71-7
표준 SMILES
CC[C@@H]1C(=O)OC[C@@H]1Cc1cncn1C
InChIKey
QCHFTSOMWOSFHM-WPRPVWTQSA-N
분자식
C11H16N2O2
평균 분자량
208.26 g/mol
단동위원소 질량
208.12117776

개요

(+)-pilocarpine is the (+)-enantiomer of pilocarpine. It has a role as an antiglaucoma drug. It is an enantiomer of a (-)-pilocarpine.

이름 및 식별자

우선 이름
Pilocarpine
IUPAC
(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one
현지명
필로카르핀
영어명
PILOCARPINE
분자식
C11H16N2O2
분자량
208.26

이름 및 동의어

pilocarpine92-13-7PilokarpinPilocarpolSyncarpineOcusert piloPilocarpinSpersacarpineOcusert pilo-20Ocusert Pilo-40Ocusert P 20ocucarpine
이름 더 보기
필로카르핀필로카르핀및그염류필로카린actone(3S,4R)-3-ethyl-4-((1-Methyl-1H-iMidazol-5-yl)Methyl)dihydrofuran-2(3H)-oneOcusertpilokarpolocusertp20
Pilocarpine muriatePiloviscPilocarpinumDTXSID1021162Spersacarpine hydrochloridePilokarpin monohydrochloride01MI4Q9DI3(3S,4R)-3-ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]oxolan-2-one

데이터베이스 식별자

CAS
54-71-7、92-13-7
PubChem CID
5910
DTXSID
DTXSID1021162
ChEMBL
CHEMBL550
ChEBI
CHEBI:8207
UNII
01MI4Q9DI3
EC Number
202-128-4
Nikkaji
J9.328I

물성

구조 계산 물성

XLogP
1.1
극성 표면적
44.1 Ų
수소 결합 공여자 수
0
수소 결합 수용자 수
3
회전 가능 결합 수
3
무거운 원자 수
15
형식 전하
0
복잡도
245

실험 및 물리화학적 성질

DrugsPharmaceuticals -> Listed in ZINC15
LogP · 2건

1.1

0.66

Color/Form · 2건

OIL OR CRYSTALS

NEEDLES

Solubility · 4건

FREELY SOL IN ETHANOL; INSOL IN DIETHYL ETHER /HCL/

SOL IN WATER, ALC, CHLOROFORM; SPARINGLY SOL IN ETHER, BENZENE; ALMOST INSOL IN PETROLEUM ETHER

SOL IN ETHANOL, DIETHYL ETHER

2.07e+00 g/L

Human Drugs · 4건

Breast Feeding; Lactation; Antiglaucoma Agents; Miotics; Muscarinic Agonists; Parasympathomimetics;

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Ophthalmological preparations > Miotics and antiglaucoma medicines

Boiling Point260 °C @ 5 MM HG (PARTIAL CONVERSION TO ISOPILOCARPINE)
DecompositionON HEATING TO DECOMP, EMITS TOXIC FUMES OF NO(X).
Melting Point · 3건

195-205

34 °C

34 °C

Optical RotationSPECIFIC OPTICAL ROTATION: +106 DEG @ 18 °C/D (2%)
Physical DescriptionSolid
Stability/Shelf Life · 3건

HYGROSCOPIC. /HCL/

SENSITIVE TO LIGHT.

STABLE IN AIR BUT AFFECTED BY LIGHT. /NITRATE/

Dissociation ConstantsPK1= 7.15; PK2= 12.57 @ 20 °C

물리화학적 성질

녹는점
34 ° · 34°
끓는 점
5 · bp5 260° (partial conversion to isopilocarpine)
밀도
1.1123 · 1.1123 (rough estimate)
굴절률
1.5 · 1.5000 (estimate)
용해도
클로로포름(소량, 초음파 처리), 메탄올(약간 용해됨)
산도 계수 (pKa)
6.87 · 6.87(at 30℃)
물리적 상태
34 °C · 34°C Liquid
색상
Colorless to light yellow
InChI
InChI=1S/C11H16N2O2/c1-3-10-8(6-15-11(10)14)4-9-5-12-7-13(9)2/h5,7-8,10H,3-4,6H2,1-2H3/t8-,10-/m0/s1
InChIKey
QCHFTSOMWOSFHM-WPRPVWTQSA-N
SMILES
O1C[C@H](CC2N(C)C=NC=2)[C@H](CC)C1=O
LogP
0.12 · 0.120
EPA
2 · 2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S,4R)- (92-13-7)

화학적 성질

Colorless crystalline solid or an oil; melts at34°C (93.2°F); dissolves in water, alcohol,and chloroform; slightly soluble in ether andbenzene.

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 6건

Danger

H300: Fatal if swallowed [Danger Acute toxicity, oral]

P260, P264, P270, P271, P284, P301+P316, P304+P340, P316, P320, P321, P330, P403+P233, P405, and P501 (click each P-code to see the statement)

Danger

H300+H330 (97.5%): Fatal if swallowed or if inhaled [Danger Acute toxicity, oral; acute toxicity, inhalation]

P260, P264, P270, P271, P284, P301+P316, P304+P340, P316, P320, P321, P330, P403+P233, P405, and P501 (click each P-code to see the statement)

유해성 정보

Regulatory InformationPilocarpine: Does not have an individual approval but may be used under an appropriate group standard
Other Safety InformationIMAP assessments - 2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-: Human health tier I assessment
Hazard Classes and Categories · 4건

Acute Tox. 2 (100%)

Acute toxicity - category 2

Acute toxicity (Oral) - Category 1

Acute Tox. 2 *

안전 및 보호

Storage ConditionsKEEP WELL CLOSED & PROTECTED FROM LIGHT. /HCL/

독성 정보

Treatment · 1건

Overdosage should be treated with atropine titration (0. 5 mg to 1. 0 mg given subcutaneously or intravenously) and supportive measures to maintain respiration and circulation. Epinephrine (0. 3 mg to 1. 0 mg, subcutaneously or intramuscularly) may also be of value in the presence of severe cardiovascular depression or bronchoconstriction. (L1712)

HepatotoxicityIn clinical trials of pilocarpine, serum enzyme elevations were uncommon and no more frequent than with placebo. Despite, wide scale use, there have been no published reports of acute liver injury attributable to pilocarpine.
Adverse Effects · 1건

As the drug acts as a cholinergic agonist, pilocarpine may propagate muscarinic side effects, particularly when used in the oral form. The muscarinic receptors are present in nearly all major organ systems, and muscarinic medications can mediate autonomic function wherever the receptors are present. Due to the receptor's role in mediating the response of the parasympathetic nervous system, stimulation of the receptors will cause "rest and digest" functions throughout the distribution of M1-M5 receptor locations: the neuronal, cardiac, musculoskeletal, pulmonary, digestive, and urinary systems.

Exposure RoutesOral ; eye contact. There was a decrease in the rate of absorption of pilocarpine from SALAGEN Tablets when taken with a high fat meal by 12 healthy male volunteers
Toxicity Summary · 2건

It is essential to monitor for side effects of excessive stimulation of the muscarinic receptors, as previously due to the systemic effects of the oral preparation. Fortunately, pilocarpine is not among the narrow therapeutic index medications. However, there is no known antidote for treating these side effects, and care should still be taken by the healthcare team to monitor doses and weigh the pros and cons of treatment. If a patient is unable to tolerate the side effects of pilocarpine, they should notify their healthcare team, who may either decrease the dose or discontinue the treatment.

Pilocarpine is a cholinergic parasympathomimetic agent. It increase secretion by the exocrine glands, and produces contraction of the iris sphincter muscle and ciliary muscle (when given topically to the eyes) by mainly stimulating muscarinic receptors.

Natural Pollution Sources · 2건

PILOCARPINE IS CHIEF ALKALOID OBTAINED FROM LEAFLETS OF SOUTH AMERICAN SHRUBS OF GENUS PILOCARPUS. ...IT WAS LONG KNOWN BY NATIVES THAT CHEWING OF LEAVES OF PILOCARPUS PLANTS CAUSED SALIVATION, 1ST EXPT WERE...PERFORMED IN 1874 BY BRAZILIAN PHYSICIAN NAME COUTINHOU.

FROM PILOCARPUS JABORANDI HOLMES, RUTACEAE: PETIT, POLANOVSKI, BULL SOC CHIM (3) 17, 557, 702 (1897).

Human Toxicity Excerpts · 5건

LOCAL IRRITATION, ALLERGIC REACTIONS, & SYSTEMIC EFFECTS ARE UNCOMMON. 1 CASE OF MALFUNCTION IN EUSTACHIAN TUBE & DISTURBANCE IN MIDDLE EAR HAS BEEN REPORTED AFTER USE OF 4% SOLN /OF PILOCARPINE/.

HAZINESS OF CORNEAL EPITHELIUM & SUPERFICIAL CORNEAL VASCULARIZATION WITH REDNESS OF CONJUNCTIVA HAVE BEEN OBSERVED...IN 2 PT AFTER LONG-CONTINUED USE OF PILOCARPINE EYEDROPS.

ADVERSE SIDE EFFECTS FROM TOPICAL USE ON EYE ARE FEW, CONSISTING OF SENSATION OF DIMNESS OF VISION...ENFORCED ACCOMMODATION FOR NEAR, CAUSING PSEUDOMYOPIA & IMPROPER FOCUSING...BY PEOPLE BELOW AGE OF PRESBYOPIA. ACHING DISCOMFORT IN EYE FROM CONTRACTION OF CILIARY MUSCLE...@ START OF TREATMENT WITH...EYEDROPS.

SALIVARY, LACRIMAL, GASTRIC, PANCREATIC, & INTESTINAL GLANDS, & MUCOUS CELLS OF RESP TRACT ARE...STIMULATED BY.../PILOCARPINE/. ...AFTER PILOCARPINE, COMPOSITION OF SALIVA TENDS TO APPROACH...ULTRAFILTRATE OF PLASMA. ... GASTRIC GLANDS...SECRETE JUICE...ESP ABUNDANT IN PEPSIN & MUCIN...

For more Human Toxicity Excerpts (Complete) data for PILOCARPINE (12 total), please visit the HSDB record page.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 6건

Drug Induced Liver Injury Rank (DILIrank 2.0)

Pilocarpine

Ambiguous-DILI-concern

3

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

Non-Human Toxicity Excerpts · 2건

ALL PARASYMPATHOMIMETIC DRUGS, IN TOXIC DOSES, STIMULATE ALL SECRETIONS & PRODUCE SEVERE GI COLIC & DIARRHEA & DYSPNEA; IRIS IS MARKEDLY CONSTRICTED; HEART RATE IS 1ST INCR & THEN SLOWED. DEATH MAY BE DUE TO RESP PARALYSIS OR HEART BLOCK. /PARASYMPATHOMIMETIC DRUGS/

...INJECTION OF PILOCARPINE INTO CEREBRAL VENTRICLES OF...RABBIT PRODUCED VARIETY OF AUTONOMIC & SOMATIC MOTOR EFFECTS...PILOCARPINE...BEEN FOUND TO EVOKE CHARACTERISTIC CORTICAL AROUSAL OR ACTIVATION RESPONSE IN CATS FOLLOWING IV INJECTION OF RELATIVELY SMALL DOSES...

Antidote and Emergency TreatmentTREATMENT CONSISTS IN PARENTERAL ADMIN OF ATROPINE, & ADEQUATE MEASURES TO SUPPORT RESP & CIRCULATION & TO COUNTERACT PULMONARY EDEMA.
Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

안전 데이터

wgk
3
tsca
TSCA listed
ridadr
1544
HS 번호
2939800000
risk_code
26/28
hazard_code
T+
safety_code
25-45
포장분류
III
위험 등급
6.1(b)
유해 물질 데이터
92-13-7(Hazardous Substances Data)

화학 및 산업

약리 정보

ATC Code · 6건

S01EB01

S - Sensory organs

N - Nervous system

QN - Nervous system

QS - Sensory organs

S01EB01

Protein BindingPilocarpine does not bind to human or rat plasma proteins over a concentration range of 5 to 25,000 ng/mL. The effect of pilocarpine on plasma protein binding of other drugs has not been evaluated.
Pharmacodynamics · 1건

Pilocarpine is a muscarinic agent that mediates diaphoretic, miotic, and central nervous system effects. Pilocarpine stimulates the secretion of various exocrine glands, such as sweat, lacrimal, salivary, and gastrointestinal glands. Following oral administration, pilocarpine increased the mean salivary flow rate by 2- to lO-folds than placebo. Its peak levels were maintained for at least one to two hours. Pilocarpine increases smooth muscle tone, contracts the pupillary and iris sphincter muscles, and induces miosis. Because pilocarpine may affect all five muscarinic receptor subtypes, it is associated with parasympathetic side effects.

Mechanism of Action · 5건

The muscarinic M3 receptor is expressed in various endocrine and exocrine glands, including the gastric and salivary glands. It is also found in smooth muscle cells in pupillary sphincter and ciliary bodies. The M3 receptor is a G<sub>q</sub>-protein-coupled receptor that activates phospholipase C and upregulates inositol trisphosphate and intracellular calcium. M3 receptor activation has been implicated in smooth muscle contraction and the stimulation of salivary glands. Pilocarpine is an agonist for M1 and M2 receptors, and is a full and partial agonist at the M3 receptor.

...ACT PRIMARILY @ MUSCARINIC RECEPTORS OF AUTONOMIC EFFECTOR CELLS, GANGLIONIC EFFECTS CAN ALSO BE OBSERVED. THIS IS PARTICULARLY TRUE OF PILOCARPINE, ALTHOUGH ITS GANGLIONIC ACTION ALSO INVOLVES STIMULATION OF MUSCARINIC RECEPTORS...

...AFTER TOPICAL INSTILLATION, MIOSIS BEGINS IN 15 TO 30 MIN & LASTS 4 TO 8 HR. REDUCTION OF INTRAOCULAR PRESSURE IS MAXIMAL IN 2 TO 4 HR, WHICH CORRELATES WITH MAX DECR IN OUTFLOW RESISTANCE. EFFECT ON INTRAOCULAR PRESSURE OUTLASTS EFFECT ON OUTFLOW FACILITY...PILOCARPINE...MAY DECR AQUEOUS PRODUCTION.

...PILOCARPINE /HAS AS/...PRINCIPAL ACTION STIMULATION OF SAME AUTONOMIC EFFECTOR CELLS AS THOSE ACTED UPON BY CHOLINERGIC POSTGANGLIONIC NERVE IMPULSES.

...PILOCARPINE...PRINCIPAL ACTION STIMULATION OF SAME AUTONOMIC EFFECTOR CELLS AS THOSE ACTED UPON BY CHOLINERGIC POSTGANGLIONIC NERVE IMPULSES. IN THIS RESPECT...RESEMBLE CHOLINE ESTERS...

Biological Half-LifeThe elimination half-life was 0.76 and 1.35 hours following administration of a 5mg or lOmg dose 3 times daily, respectively. Following ophthalmic administration in healthy subjects, the half-life was 3.96 hours.
Metabolism/Metabolites · 3건

There is limited information available about the metabolism of pilocarpine in humans. Inactivation of pilocarpine can occur at neuronal synapses and probably in plasma. Pilocarpine is reported to undergo CYP2A6-mediated 3-hydroxylation to form stereoisomers of 3-hydroxypilocaripine. Pilocaripine also undergoes hydrolysis mediated by paraoxonase 1, a calcium-dependent esterase in plasma and the human liver. Pilocarpic acid is a possible metabolic product of hydrolysis. Pilocarpine metabolites are reported to possess negligible or no pharmacological activity.

Pilocarpine has known human metabolites that include 3-hydroxypilocarpine.

Possibly occurs at the neuronal synapses and in the plasma Half Life: 0.76 hours

FDA Pharmacological Classification · 6건

01MI4Q9DI3

PILOCARPINE

Mechanisms of Action [MoA] - Cholinergic Agonists

Mechanisms of Action [MoA] - Cholinergic Muscarinic Agonists

Established Pharmacologic Class [EPC] - Cholinergic Receptor Agonist

Pilocarpine is a Cholinergic Receptor Agonist. The mechanism of action of pilocarpine is as a Cholinergic Agonist and Cholinergic Muscarinic Agonist.

MeSH Pharmacological Classification · 2건

Agents causing contraction of the pupil of the eye. Some sources use the term miotics only for the parasympathomimetics but any drug used to induce miosis is included here.

Drugs that bind to and activate muscarinic cholinergic receptors (RECEPTORS, MUSCARINIC). Muscarinic agonists are most commonly used when it is desirable to increase smooth muscle tone, especially in the GI tract, urinary bladder and the eye. They may also be used to reduce heart rate.

Absorption, Distribution and Excretion · 6건

Following oral administration of pilocarpine 5mg three times daily in healthy male subjects, peak plasma drug concentrations of 15μg/L were reached in 1.25 hours. At the dose of pilocarpine 10mg three times daily, peak plasma drug concentrations of 41μg/L were reached in 0.85 hours. The rate of absorption is increased when taken with food. Following ophthalmic administration in healthy subjects, the overall median Tmax was 2.2 hours. The mean (SD) Cmax and AUC0-t were 897.2 (287.2) pg/mL and 2699 (741.4) hr x pg/mL, respectively. In patients with presbyopia, the mean Cmax and AUC0-t,ss values were 1.95 ng/mL and 4.14 ng x hr/mL, respectively. The median Tmax was 0.3 hours postdose with a range from 0.2 to 0.5 hours post-dose.

Pilocarpine and its degradation products are eliminated predominantly in the urine.

There is no information available.

There is no information available.

LITTLE DEFINITIVE INFORMATION IS AVAIL ON FATE & ELIMINATION OF PILOCARPINE. IT IS PARTLY DESTROYED IN BODY, BUT LARGER FRACTION IS EXCRETED IN URINE IN COMBINED FORM.

PILOCARPINE PENETRATES EYE WELL; AFTER TOPICAL INSTILLATION...

Cellular LocationsMembrane

용도 및 제조

Uses · 4건

MEDICATION (VET)

MEDICATION

Use (kg; approx.) in Germany (2009): >75

For the treatment of radiation-induced dry mouth (xerostomia) and symptoms of dry mouth in patients with Sj&ouml;grens syndrome.

Methods of Manufacturing · 2건

TOTAL ALKALOIDS ARE EXTRACTED FROM...SUITABLE PILOCARPUS SPECIES, WITH ALC CONTAINING SMALL AMT OF HYDROCHLORIC ACID. SOLVENT DISTD OFF...RESINS ARE ALL DEPOSITED. ...FILTERED...EVAPORATED TO SMALL BULK. AMMONIA IS ADDED IN EXCESS & FREE ALKALOIDS EXTRACTED WITH CHLOROFORM.

PREOBRASHENSKI ET AL, BER 66, 1187 (1933); SAMOKH ALOV, MED PROM SSSR 11, NO 2, 10 (1957)...

Formulations/Preparations · 2건

ADSORBOCARPINE (BURTON, PARSONS)...ALMOCARPINE (AYERST)...ISOPTO CARPINE (ALCON)...MI-PILO (BARNES-HIND)...MISTURA P (LEDERLE)...PILOCAR (SMP)...PILOCEL (SOFTCON PRODUCTS)...PILOMIOTON (SMP)... /HCL/; PV CARPINE LIQUIFILM (ALLERGAN)...PILOFRIN LIQUIFILM (ALLERGAN)... /NITRATE/

OCUSERT PILO-20, PILO-40 /(ALZA)/

General Manufacturing Information · 5건

2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S,4R)-: ACTIVE

/PILOCARPINE/ HAS CIS CONFIGURATION; ISOPILOCARPINE IS TRANS: ZAV'VANOL, DOKLADY ADAD NAUK SSSR 82, 257 (1952). ABSOLUTE CONFIGURATION: HILL, BARCZA, TETRAHEDRON 22, 2889 (1966).

INCOMPATIBILITIES: SILVER NITRATE, MERCURY BICHLORIDE, IODIDES, GOLD SALTS, TANNIN, CALOMEL, POTASSIUM PERMANGANATE, ALKALIES.

/OCUSERT/...IS ELLIPTICALLY SHAPED UNIT...OF PILOCARPINE-CONTAINING RESERVOIR SURROUNDED BY PERMEABLE MEMBRANE. FOLLOWING PLACEMENT BY PT, DIFFERENT FORMS OF UNIT ARE DESIGNED TO RELEASE PILOCARPINE @ RATE OF EITHER 20 OR 40 UG/HR FOR 1 WK. INTRAOCULAR PRESSURE IS REDUCED CONTINUOUSLY...WITH...LESS TOTAL DRUG...

PILOCARPINE HYDROCHLORIDE & PILOCARPINE NITRATE ARE OFFICIAL IN USP BOTH AS SALTS & AS OPHTHALMIC SOLN. AVG ORAL OR HYPODERMIC DOSE OF PILOCARPINE, NOW RARELY USED, IS 5 TO 10 MG. DEVICE FOR ACHIEVING SUSTAINED RELEASE OF PILOCARPINE INTO CUL-DE-SAC OF EYE IS ALSO AVAIL (OCUSERT).

응용 분야 · 3건

개요Pilocarpine acts by stimulating muscarinic receptors, therefore making it similar in action to acetylcholine when systematically introduced. This compound differs from acetylcholine in that it does not react with any nicotinic receptors, but by stimulating the CNS. Its effects are blocked by atropine. It has found therapeutic use in ophthalmology as a myotic agent.

역사It has a history of hundreds of years since pilocarpine was used to treat glaucoma .In 1933, the chemical synthesis of pilocarpine was firstly reported. However, pilocarpine couldn’t be used for treatments, because its synthetic route is so long and focuses on isopilocarpine, of which the pharmacological activities are 1/20– 1/50 of pilocarpine. In 1972, DeGraw successfully synthesized the cis-homopilopic acid employing catalytic hydrogenation of precious metals and obtained pilocarpine as the main part product. Therefore, the study on the production of pilocarpine by chemical synthesis has made new progress and has been artificially synthesized .

용도Pilocarpine occurs in the leaves of variousspecies of pilocarpus. It is used as an antidotefor atropine poisoning and in ophthalmologyto produce contraction of the pupil.

상·하류 제품 정보

상류 원료

염산디이소부틸알루미늄하이드라이드수소화나트륨Palladium hydroxide4-다이메틸아미노피리딘3-Acetyl-2(5H)-furanone(4-에틸-5-옥소-테트라히드로-푸란-3-일)-아세탈데하이드부탄디오산,2-브로모-3-에틸-,4-메틸에스테르,[S-(R*,S*)]-(9CI)

추가 설명

정의ChEBI: The (+)-enantiomer of pilocarpine.

관련 반응

10건
반응 기록 만들기
HRID 1448028 반응식
HRID 1448028생성물로
HRID 1461496 반응식
HRID 1461496생성물로
HRID 1496356 반응식
HRID 1496356반응물로
HRID 1723310 반응식
HRID 1723310반응물로
HRID 1723311 반응식
HRID 1723311반응물로
HRID 2248544 반응식
HRID 2248544반응물로
HRID 2248545 반응식
HRID 2248545반응물로
HRID 2254018 반응식
HRID 2254018반응물로
이전1 / 2 페이지

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트